Andrew Stiff
Immunology and Microbiology · The Ohio State University
Publications
113
Citations
1,321
Est. group size
~23
Recurring co-author estimate
Active years
15
Publishing since 2012
Andrew Stiff's research focuses on blood cancers, particularly leukemia, and how immune cells such as myeloid-derived suppressor cells respond to targeted drug therapies. Work in this area involves analyzing patient samples using techniques like single-cell RNA sequencing to understand how cancer cells and immune cells interact and how they respond to treatments such as Bruton's Tyrosine Kinase inhibitors. The research aims to inform prognosis and treatment strategies for conditions including acute myeloid leukemia, hairy cell leukemia, and metastatic breast cancer.
Publication output was relatively steady and modest from 2017 through 2022, then increased sharply in 2023 and 2024 before dropping off in 2025-2026, though the recent surge is largely driven by supplementary data files linked to a single dataset publication.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia
Leukemia · 2026
- Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia
eJHaem · 2024
- An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer
Cancer Control · 2024
- Supplementary Figure 3 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 4 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Data from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 8 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 6 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 1 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 5 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Figure 7 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Table 2 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Table 4 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Table 4 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Supplementary Table 6 from Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase
2024
- Cancer Research×9
- Blood×9
- Proceedings of the National Academy of Sciences×2
- Scientific Reports×2
- Oncotarget×2
- Gang Xin
Immunology and Microbiology · The Ohio State University
- Carter Allen
Immunology and Microbiology · The Ohio State University
- Alexander Abreo
Immunology and Microbiology · The Ohio State University
- Hyeongseon Jeon
Immunology and Microbiology · The Ohio State University
- Jianying Li
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile